Ali-Jackson Kamil
Rigel Pharmaceuticals, Inc. · Director
Ali-Jackson Kamil is listed in public filings as director. This Ali-Jackson Kamil insider trading page organizes Form 4 disclosures, reported purchases and sales, transaction dates, share amounts, related issuers, and historical insider activity so readers can review the person's public trading record in one place. Companies and tickers connected to this insider trading profile include Rigel Pharmaceuticals, Inc. (RIGL), and PDS Biotechnology Corporation (PDSB). Investors use Ali-Jackson Kamil's insider trading disclosures to study buying and selling patterns, position changes, company-specific activity, and the source evidence behind each reported transaction.
Latest Actions
| Company | Holding Value | Last Transaction | Amount | Transaction Price | Current Price |
|---|---|---|---|---|---|
| $368k12.6k shares | SellMay 26, 2026 | $72.9K2.5k shares | $29.17 | -- |
Insider Trades History
| Company | Holding Value | Last Transaction | Amount | Transaction Price | Current Price |
|---|---|---|---|---|---|
| --15.1k shares | Grant / ExerciseMay 15, 2026 | Disclosure amount unavailable5.8k shares | -- | -- | |
| $54k54.9k shares | Grant / ExerciseJan 12, 2026 | $53.8K54.9k shares | $0.98 | -- | |
| $40k22.7k shares | Grant / ExerciseJun 11, 2025 | $39.7K22.7k shares | $1.75 | -- | |
| --9.4k shares | Grant / ExerciseMay 23, 2025 | Disclosure amount unavailable2.5k shares | -- | -- | |
| $57k3k shares | Grant / ExerciseMay 23, 2025 | $56.9K3k shares | $18.95 | -- | |
| $26k9k shares | Grant / ExerciseJun 24, 2024 | $25.7K9k shares | $2.86 | -- |